SEC filing record
Primary Source · SEC.gov

Levee Medical, Inc.

2025 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalSold increasedForm D/A · 2026-05-055 events: 2 new form d filer, 1 sold increased, 1 offering upsizedLast filing 2026-05-05

Raised

$13M

Investors

130

Min Invest

None stated

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Levee Medical, Inc. is a Delaware corporation that first filed a Form D on August 24, 2021 and most recently amended it on May 5, 2026 in the Other Health Care industry group. The offering claims Rule 506(b) and covers debt. Levee Medical, Inc. reported $12,500,000 sold from 130 investors of a $12,500,000 total offering as of the Form D filed May 5, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates. The issuer's address of record is 4819 Emperor Boulevard, Suite 400, Durham, NC 27703.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001877814
Entity NameLevee Medical, Inc.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationDelaware
Issuer Address4819 Emperor Boulevard, Suite 400, Durham, NC 27703
Phone(919) 633-5979
Former NamesLuvaura, Inc. (until August 24, 2021)
Industry / Fund TypeOther Health Care
Securities TypeDebt
First Sale DateOctober 31, 2025
Filing DateMay 5, 2026
Accession Number0001877814-26-000002
Total Offering Amount$12,500,000
Total Amount Sold$12,500,000
Amount Remaining$0
Total Investors130
Non-Accredited InvestorsNone
Minimum Investment$0 (no stated minimum)
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeDecline to Disclose
State (Issuer Address)NC
Amendment Count8 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

5

latest May 5, 2026

Critical / warning

0 / 0

2 watch · 3 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

5

closed, lapsed

Latest event Sold increase · May 5, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 5 filing events with values and deltas, latest 2026-05-05, and alerts on the next one
  • 5 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Bruce Choi

Executive Officer, Director · Durham, NC

Adam Irving

Executive Officer, Director · Durham, NC

Gary McCord

Director · Durham, NC

Peter Mulrooney

Director · Durham, NC

Mike Henson

Director · Durham, NC

Questions About Levee Medical, Inc.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Levee Medical, Inc.?

Levee Medical, Inc. is a Delaware corporation that filed a Form D with the SEC on May 5, 2026 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of debt.

Is Levee Medical, Inc. legit?

AltStreet does not rate legitimacy; it reports the public record. Levee Medical, Inc. filed a Form D with the SEC on May 5, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $12,500,000 sold to 130 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Levee Medical, Inc. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Levee Medical, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Levee Medical, Inc. raised?

Levee Medical, Inc. reported $12,500,000 sold from 130 investors of a $12,500,000 total offering as of the Form D filed May 5, 2026.

Who can invest in Levee Medical, Inc.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The filing lists the minimum investment as $0, meaning no minimum was stated.

What is the minimum investment in Levee Medical, Inc.?

The Form D lists the minimum investment as $0, which means the issuer did not state a minimum on the form. The offering documents, not the Form D, set the actual subscription terms.

Who is selling Levee Medical, Inc. and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Levee Medical, Inc.?

The Form D lists 5 related persons: Bruce Choi, executive officer, director; Adam Irving, executive officer, director; Gary McCord, director; Peter Mulrooney, director; Mike Henson, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Levee Medical, Inc. located?

The issuer's address on its SEC filings is 4819 Emperor Boulevard, Suite 400, Durham, NC 27703. Its phone number of record is 919-633-5979. It is organized under the laws of Delaware.

How long is the Levee Medical, Inc. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 3 amendments are on record for this CIK.

What is Levee Medical, Inc.'s revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.